Nasdaq: APMD · Listed Jul 31, 2026
Apnimed IPO
IPO price
$16.00
Apnimed (APMD) priced its IPO at $16.00 a share and has traded on Nasdaq since Jul 31, 2026.
APMD today$17.35+8.44%since IPO15-min delayed · as of 7:48:47 PM EST on Nov 18, 2026
See the APMD quoteFirst trading day · Jul 31, 2026
- IPO price
- $16.00
- the top of the range of $14 to $16
- First trade
- $22.00
- +37.50% from the IPO price
- First-day last trade
- $24.69
- +54.31% from the IPO price, regular session
- Raise
- $192M
- before the underwriters' option
These numbers are from the first trading day, Jul 31, 2026.
How APMD did against the market
APMD against the market, from its first trade at 11:45 ET to the last trade of the session.
- APMD from its first trade
- +12.23%
- Against the market (QQQ)
- +11.6 pts
APMD rose 12.2% from its first trade to the last trade of the session. That is 11.6 points better than the market.
Same-day moves do not show that APMD caused them. The market is QQQ, the Nasdaq-100 ETF.
The debut race
APMD against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
APMD against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Apnimed '26 | $192M | +37.50% | +54.31% | +74.94% | +63.87% | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Apnimed IPO offers 12M shares to raise $192M, before any underwriters' option.
- Expected price range
- $14 to $16
- IPO price
- $16.00
- Shares offered
- 12M
- Money raised
- $192M
- Listing date
- Jul 31, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Apnimed$192M
Where APMD ranks
Apnimed's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- APMD$726.46M
APMD news
The latest news and headlines about Apnimed (APMD).
- Obstructive Sleep Apnea Clinical Trial and Competitive Landscape Expands as 18+ Leading Companies Accelerate Drug Development | DelveInsightpositiveGlobeNewswire Inc.· Oct 29, 2026
- Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional SharespositiveGlobeNewswire Inc.· Aug 3, 2026
Filings and the company
What Apnimed has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Apnimed discloses to the SEC on Form 8-K.
- Financial restatementNov 13, 2026
The Audit Committee ... concluded that the Company's previously issued financial statements ... should no longer be relied upon due to an error identified in the classification of the gain on the disposition of the Company's equity method investment in ... SASS for the three and six months ended June 30, 2026 as a gain in continuing operations rather than discontinued operations.
- Quarterly earningsSep 8, 2026
On September 8, 2026, Apnimed, Inc. issued a press release announcing its financial results for the quarterly period ended June 30, 2026.
- Charter amendmentAug 3, 2026
on August 3, 2026, the Company filed its ninth amended and restated certificate of incorporation (the "Restated Certificate") with the Secretary of State of the State of Delaware... The Restated Certificate amends and restates the Company's existing eighth amended and restated certificate of incorporation, as amended, in its entirety to, among other things: (i) authorize 500,000,000 shares of common stock and (ii) eliminate all references to the previously existing series of preferred stock; and (iii) authorize 10,000,000 shares of undesignated preferred stock that may be issued from time to time by the Board in one or more series.
About Apnimed
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
- Ticker
- APMD
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Industry
- PHARMACEUTICAL PREPARATIONS
- Listed
- Jul 31, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the Apnimed IPO price?
$16.00 a share.
When did Apnimed go public?
Apnimed listed on Nasdaq on Jul 31, 2026 under the ticker APMD.
How much did the Apnimed IPO raise?
$192M, before any underwriters' option.
How did Apnimed open on its first day?
APMD first traded at $22.00, +37.50% from the IPO price of $16.00.
How did APMD close on its first day?
Its last regular-session trade was $24.69, +54.31% from the IPO price of $16.00.
What was the APMD first-day trading range?
$16.12 to $29.15 in the regular session.
How many APMD shares traded on the first day?
3.29M shares in the regular session.
How many shares did Apnimed sell in its IPO?
12M shares.
How did APMD do against the market on its first day?
APMD rose 12.2% from its first trade to the last trade of the session. That is 11.6 points better than the market (QQQ, the Nasdaq-100 ETF).
What exchange is APMD listed on?
Apnimed lists on Nasdaq under the ticker APMD.
Build with Massive
Get the APMD data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/APMD/range/5/minute |
| Market cap | /v3/reference/tickers/APMD |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.